Vito J. Palombella
Harvard University
Tell me more about Vito J. Palombella?
Vito J. Palombella, Ph.D., has been serving as the Chief Scientific Officer of Infinity since 2010. He has extensive experience in the pharmaceutical industry, having held various positions at Infinity and Syntonix Pharmaceuticals. He has also worked as a senior director of cell and molecular biology at Millennium Pharmaceuticals and as a post-doctoral fellow at Harvard University. With a background in microbiology and viral oncology, Palombella has a strong understanding of the regulatory environment and has contributed to the development of Velcade, a proteasome inhibitor for cancer therapy.
For inquiries about Phone Number and Email, please click here Unlock Contact
Emails and Phone Numbers
About
Vito J. Palombella, Ph.D., has served as Infinity’s chief scientific officer since 2010. He is responsible for the company’s drug discovery and preclinical development activities. Prior to his role as chief scientific officer, Dr. Palombella was vice president, biology and then vice president, drug discovery at Infinity. Prior to joining Infinity in 2004, Dr. Palombella served as director of molecular biology and protein chemistry at Syntonix Pharmaceuticals where he was responsible for improving and expanding its core Fc receptor-mediated drug delivery technology. Before joining Syntonix, Dr. Palombella served as senior director of cell and molecular biology at Millennium Pharmaceuticals, which he joined through its acquisition of LeukoSite in 1999. Prior to its acquisition by LeukoSite, Dr. Palombella held a number of positions at ProScript, Inc. While at ProScript, LeukoSite and Millennium, Dr. Palombella was involved in the discovery and development of Velcade® (bortezomib), a proteasome inhibitor for cancer therapy. He also managed a number of additional projects, including research into NF-KB regulation. Dr. Palombella received his B.S. in microbiology from Rutgers University and his M.S. and Ph.D. in viral oncology and immunology from the New York University Medical Center. He was also a post-doctoral fellow at Harvard University in the laboratory of Tom Maniatis, Ph.D.
...See MoreWork Experience
Chief Scientific Officer
Biotechnology Research
Vito J. Palombella's Professional Milestones
- Chief Scientific Officer (2010-01-01~2016-01-01): Revolutionizing the field by establishing new scientific partnerships and increasing scientific expertise.
- Vice President, Biology: Revolutionizing research and innovation, pushing the boundaries of scientific knowledge and achieving groundbreaking results.
Education
Post Doctoral
Certification
Colleagues
Andrew Lake
Vice President of Cell Biology
Robert Ross
chief executive officer at surface oncology inc
Jessica Fees
Chief Financial Officer
Alison M. O'Neill, MD
Chief Medical Officer
Lisa McGrath
Chief People Officer
Other Named Vito J. Palombella
Frequently asked questions
We found 2 Vito J. Palombella's phone numbers
Vito J. Palombella's social media include: Linkedin,
Vito J. Palombella works for Surface Oncology Inc.
Vito J. Palombella's role in Surface Oncology Inc. is Chief Scientific Officer
Vito J. Palombella works in the industry of Biotechnology Research
Vito J. Palombella's colleagues are Andrew Lake,Robert Ross,Jessica Fees
Vito J. Palombella's latest job experience is Chief Scientific Officer at Surface Oncology Inc.
Vito J. Palombella's latest education in Harvard University